SAN DIEGO, CA, MedCrypt today announced additional funding from Dexcom Ventures, the corporate venture capital arm of Dexcom.
MedCrypt, the proactive cybersecurity solution provider for medical device manufacturers, today announced additional funding from Dexcom Ventures, the corporate venture capital arm of Dexcom. This extension follows MedCrypt's Series B funding round in November 2022 with investments from Intuitive Ventures, Johnson & Johnson Innovation - JJDC, Inc. (JJDC), among others, bringing the company's funding to date to $36.4 million.
MedCrypt is a medical device cybersecurity technology provider that uses cryptography to protect data sent to and from medical devices. MedCrypt's security software ensures data delivered to devices comes from a trusted source and provides remote, real-time monitoring to alert vendors of suspicious behaviors that may yield potential security threats to their company, devices and users.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about